Dipanwita Das is transforming how the life sciences industry delivers medical insights as CEO and Co-founder of Sorcero, whose AI platform is used by nearly a quarter of the world's top pharma companies. Holding six biomedical AI patents and recognized as a Sir Edmund Hillary Fellow, she has partnered with Google and Springer Nature to build medically-tuned AI that accelerates treatments to patients. Before Sorcero, she built the digital platform for a public health initiative reaching over three billion people, bringing that same drive for large-scale human impact to every problem she tackles.